BIOTRIAL INTERNATIONAL LIMITED

Figures converted to GBP from EUR at 0.870 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +24%

  £27,917,289 → £34,623,597

• Cash

  -18.5%

  £916,649 → £746,884

• Net assets

  -2.6%

  £2,323,946 → £2,264,326

• Employees

  -14.3%

  7 → 6

• Operating profit

  -66.9%

  £1,540,464 → £510,001

• Profit before tax

  -67.7%

  £1,554,397 → £501,734

• Wages

  -11.1%

  £241,027 → £214,339

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors consider the going concern basis to be appropriate having forecasts and given due consideration to the long-term financing obtained at group level, support provided by group companies, bank financing within the group, the working capital requirements and the profits and cash generation anticipated by the company.”

Group structure

1. BIOTRIAL INTERNATIONAL LIMITED · parent
   1. SAS Biotrial Research · France
   2. Biotrial SA · France
   3. Biotrial Pharmacology · France
   4. Biotrial Rennes SA · France
   5. Biotrial Paris SAS · France
   6. SARL Biotrial Neuroscience · France
   7. SARL Biotrial Biometrics · France
   8. Biotrial Inc · USA
   9. Biotrial Bioanalytical Services · Canada
   10. Biolab · France

Significant events

• “There have been no significant events affecting the company since the year end.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.